Search

Your search keyword '"Ansheles A."' showing total 331 results

Search Constraints

Start Over You searched for: Author "Ansheles A." Remove constraint Author: "Ansheles A."
331 results on '"Ansheles A."'

Search Results

1. Current possibilities of nuclear imaging in arterial hypertension

2. Improvement of the technique of positioning the endocardial electrodes of the cardiac contractility modulation device in patients with CHF with reduced ejection fraction and atrial fibrillation

3. Expert Center for cardiac amyloidosis: reality and perspectives

4. Difficulties in differential diagnosis of the AL- and ATTR-cardiac amyloidosis. Case report

5. Worldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19.

6. Positron emission tomography in cardiological practice

7. Impact of COVID-19 on the imaging diagnosis of cardiac disease in Europe.

8. A clinical case of hereditary transthyretin amyloidosis. Case report

9. Cardiovascular prevention 2022. Russian national guidelines

10. Disorders of lipid metabolism. Clinical Guidelines 2023

11. The Role of Scintigraphy and Hybrid Single-Photon Emission Tomography in Comparison with Laboratory Data in a Comprehensive Examination of Patients with Secondary Hyperparathyroidism

12. Myocardial scintigraphy with 99mTc-pyrophosphate in the diagnosis of cardiac amyloidosis: place in the diagnostic algorithm, features of the implementation and interpretation of the study

13. Practical guidelines for the diagnosis and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM or transthyretin cardiac amyloidosis)

14. Current status of nuclear cardiology in the Russian Federation

15. Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia

16. Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia: The IAEA INCAPS-COVID Study

17. Analysis of the restoration of cardiology diagnostics scope in the Russian Federation during the COVID-19 pandemic: results of the Russian segment of the INCAPS COVID 2 study under the auspices of the International Atomic Energy Agency

18. Possibilities of Evaluating the Dynamics of Left Ventricular Perfusion and Contractility in Patients with Chronic Heart Failure after Implantation of a Heart Contractility Modulator Using Perfusion Single-Photon Emission Computed Tomography

19. International Impact of COVID-19 on the Diagnosis of Heart Disease

20. Nuclear medicine and molecular imaging in clinical practice: yesterday, today and tomorrow

21. Mobile application 'Aterostop' for a comprehensive assessment of cardiovascular risk in patients in the Russian population

22. EURASIAN ASSOCIATION OF CARDIOLOGY (EAC) GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (2020)

24. EURASIAN ASSOCIATION OF CARDIOLOGY (EAC)/ RUSSIAN NATIONAL ATHEROSCLEROSIS SOCIETY (RNAS, RUSSIA) GUIDELINES FOR THE DIAGNOSIS AND CORRECTION OF DYSLIPIDEMIA FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROSIS (2020)

25. Myocardial perfusion single-photon emission computer tomography and coronary angiography results in patients with different pretest probability of ischemic heart disease

26. Interpretation of myocardial perfusion SPECT with attenuation correction. Part 2

28. Impact of COVID-19 on the imaging diagnosis of cardiac disease in Europe

29. Left ventricular myocardial cellular perfusion against the background of cardiac contractility modulation in patients with heart failure and atrial fibrillation

32. MYOCARDIAL PERFUSION AND NEUROTROPIC SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY FEATURES IN PATIENTS WITH PRIMARY PULMONARY HYPERTENSION

33. Relationship of obesity, low-density lipoprotein cholesterol and myocardial perfusion in patients with risk factors and without atherosclerotic cardiovascular diseases

34. Nuclear imaging of chemotherapy-induced cardiotoxicity

35. Impact of the first wave of coronavirus disease 2019 (COVID-19) pandemic on the diagnosis of heart disease in the Russian Federation: results from the Russian segment of the IAEA INCAPS COVID study

36. Worldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19

37. The Revival of the 'Ischemic' Approach in the Assessment of Ischemic Heart Disease: Analysis of Major World Research

38. NUCLEAR IMAGING IN SUDDEN CARDIAC DEATH RISK ASSESSMENT

39. NUCLEAR IMAGING IN THE DIAGNOSIS OF CARDIAC AMYLOIDOSIS

40. IDENTIFICATION OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN THE RUSSIAN POPULATION USING THE EXAMPLE OF MOSCOW CITY AND MOSCOW REGION

42. Anatomical and Functional Approaches in the Assessment of Ischemia in Ischemic Heart Disease: Analysis of Major World Research

43. Worldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19

44. NEUROTROPIC MYOCARDIAL SCINTIGRAPHY IN THE EVALUATION OF SUDDEN CARDIAC DEATH PROGNOSIS IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY

45. NEW APPROACH OF QUANTITATIVE NUCLEAR CARDIAC PERFUSION ASSESSMENT IN PATIENTS WITH PULMONARY HYPERTENSION

46. Cardiovascular prevention 2022. Russian national guidelines

48. Current status of nuclear cardiology in the Russian Federation

50. Standardization of 123I-metaiodobenzylguanidine cardiac neurotropic scintigraphy and single-photon emission tomography

Catalog

Books, media, physical & digital resources